On March 11, 2019 Nymox Pharmaceutical Corporation (NASDAQ:NYMX) reported that it will hold a teleconference for shareholders on March 25, 2019 (Press release, Nymox, MAR 11, 2019, View Source [SID1234534198]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Management will discuss the Company’s current business progress with an update on its regulatory submission activities in the US and EU. Further details re time and coordinates and information for the call will be provided prior to the teleconference.

For more information please contact [email protected] or 800-936-9669.